APA (7th ed.) Citation

Geidel, G., Bänsch, S., Adam, L., Fekade, N., Rünger, A., Zell, T., . . . Haferkamp, S. (2026). Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis. Journal of the European Academy of Dermatology & Venereology, 1. https://doi.org/10.1111/jdv.70307

Chicago Style (17th ed.) Citation

Geidel, Glenn, et al. "Role of Comorbidities and Medication on Immunotherapy Efficacy in CSCC: A DeCOG Multicentre Analysis." Journal of the European Academy of Dermatology & Venereology 2026: 1. https://doi.org/10.1111/jdv.70307.

MLA (9th ed.) Citation

Geidel, Glenn, et al. "Role of Comorbidities and Medication on Immunotherapy Efficacy in CSCC: A DeCOG Multicentre Analysis." Journal of the European Academy of Dermatology & Venereology, 2026, p. 1, https://doi.org/10.1111/jdv.70307.